Document Classification

Section Type: METHODS

Text: Five hundred fifty-two eligible patients with limited - (LD) and extensive-stage (ED) SCLC were randomized to receive one of the following regimens : arm A, P 30 mg/m2 by intravenous (IV) bolus followed by E 130 mg/m2 bolus ; arm B, E 130 mg/m2 bolus followed by P 30 mg/m2 bolus ; arm C, E 130 mg/m2 by 24-hour infusion and P 30 mg/m2 bolus at the end of each 24-hour infusion of E ; arm D, E 130 mg/m2 by 24-hour infusion and P 45 mg/m2 by 24-hour infusion on day 2 and 3 only.